Kinetics of MHC-CD8 interaction at the T cell membrane

Journal of Immunology

Volumn 179, Issue 11, 2007, Pages 7653-7662

  Huang, Jun ^a   Edwards, Lindsay J ^c   Evavold, Brian D ^c   Zhu, Cheng ^a,b  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHOLESTEROL OXIDASE; HETERODIMER; HOMODIMER; MAJOR HISTOCOMPATIBILITY ANTIGEN; PHOSPHOTRANSFERASE; SILVER; HISTOCOMPATIBILITY ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CD8+ T LYMPHOCYTE; CELL ADHESION; CELL INTERACTION; CELL KINETICS; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE MEMBRANE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; ANIMAL; BINDING SITE; CELL MEMBRANE; CHEMISTRY; IMMUNOLOGY; KINETICS; METABOLISM;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD8; BINDING SITES; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION; CELL MEMBRANE; HISTOCOMPATIBILITY ANTIGENS; HUMANS; KINETICS; MEMBRANE MICRODOMAINS; MICE; MICE, TRANSGENIC; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL;

EID: 38349108802     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.11.7653     Document Type: Article

References (60)

1. Cole, D. K., and G. F. Gao. 2004. CD8: adhesion molecule, co-receptor and immuno-modulator. Cell. Mol. Immunol. 1: 81-88.
2. Rudolph, M. G., R. L. Stanfield, and I. A. Wilson. 2006. How TCRs bind MHCs, peptides, and coreceptors. Annu. Rev. Immunol. 24: 419-466.
3. Wyer, J. R., B. E. Willcox, G. F. Gao, U. C. Gerth, S. J. Davis, J. I. Bell, P. A. van der Merwe, and B. K. Jakobsen. 1999. T cell receptor and coreceptor CD8 alphaα bind peptide-MHC independently and with distinct kinetics. Immunity 10: 219-225.
4. lck complexes. J. Exp. Med. 194: 1485-1495.
5. Gakamsky, D. M., I. F. Luescher, A. Pramanik, R. B. Kopito, F. Lemonnier, H. Vogel, R. Rigler, and I. Pecht. 2005. CD8 kinetically promotes ligand binding to the T-cell antigen receptor. Biophys. J. 89: 2121-2133.
6. Campanelli, R., B. Palermo, S. Garbelli, S. Mantovani, P. Lucchi, A. Necker, E. Lantelme, and C. Giachino. 2002. Human CD8 co-receptor is strictly involved in MHC-peptide tetramer-TCR binding and T cell activation. Int. Immunol. 14: 39-44.
7. Daniels, M. A., and S. C. Jameson. 2000. Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers. J. Exp. Med. 191: 335-346.
8. Delon, J., C. Gregoire, B. Malissen, S. Darche, F. Lemaitre, P. Kourilsky, J. P. Abastado, and A. Trautmann. 1998. CD8 expression allows T cell signaling by monomeric peptide-MHC complexes. Immunity 9: 467-473.
9. Lyons, G. E., T. Moore, N. Brasic, M. Li, J. J. Roszkowski, and M. I. Nishimura. 2006. Influence of human CD8 on antigen recognition by T-cell receptor-transduced cells. Cancer Res. 66: 11455-11461.
10. Alam, S. M., P. J. Travers, J. L. Wung, W. Nasholds, S. Redpath, S. C. Jameson, and N. R. Gascoigne. 1996. T-cell-receptor affinity and thymocyte positive selection. Nature. 381: 616-620.
11. Kersh, G. J., E. N. Kersh, D. H. Fremont, and P. M. Allen. 1998. High- and low-potency ligands with similar affinities for the TCR: the importance of kinetics in TCR signaling. Immunity 9: 817-826.
12. Gao, G. F., J. Tormo, U. C. Gerth, J. R. Wyer, A. J. McMichael, D. I. Stuart, J. I. Bell, E. Y. Jones, and B. K. Jakobsen. 1997. Crystal structure of the complex between human CD8α(α) and HLA-A2. Nature 387: 630-634.
13. Gao, G. F., Z. Rao, and J. I. Bell. 2002. Molecular coordination of alphaβ T-cell receptors and coreceptors CD8 and CD4 in their recognition of peptide-MHC ligands. Trends Immunol. 23: 408-413.
14. Pecht, I., and D. M. Gakamsky. 2005. Spatial coordination of CD8 and TCR molecules controls antigen recognition by CD8+ T-cells. FEBS Lett. 579: 3336-3341.
15. Yachi, P. P., J. Ampudia, N. R. Gascoigne, and T. Zal. 2005. Nonstimulatory peptides contribute to antigen-induced CD8-T cell receptor interaction at the immunological synapse. Nat. Immunol. 6: 785-792.
16. Bosselut, R., S. Kubo, T. Guinter, J. L. Kopacz, J. D. Altman, L. Feigenbaum, and A. Singer. 2000. Role of CD8β domains in CD8 coreceptor function: importance for MHC I binding, signaling, and positive selection of CD8+ T cells in the thymus. Immunity 12: 409-418.
17. Chang, H. C., K. Tan, and Y. M. Hsu. 2006. CD8alphaβ has two distinct binding modes of interaction with peptide-major histocompatibility complex class I. J. Biol. Chem. 281: 28090-28096.
18. Kern, P. S., M. K. Teng, A. Smolyar, J. H. Liu, J. Liu, R. E. Hussey, R. Spoerl, H. C. Chang, E. L. Reinherz, and J. H. Wang. 1998. Structural basis of CD8 coreceptor function revealed by crystallographic analysis of a murine CD8alphaα ectodomain fragment in complex with H-2Kb. Immunity 9: 519-530.
19. Gangadharan, D., and H. Cheroutre. 2004. The CD8 isoform CD8alphaα is not a functional homologue of the TCR co-receptor CD8alphaα. Curr. Opin. Immunol. 16: 264-270.
20. Devine, L., D. Thakral, S. Nag, J. Dobbins, M. E. Hodsdon, and P. B. Kavathas. 2006. Mapping the binding site on CD8 β for MHC class I reveals mutants with enhanced binding. J. Immunol. 177: 3930-3938.
21. Sun, J., and P. B. Kavathas. 1997. Comparison of the roles of CD8 α α and CD8 α β in interaction with MHC class I. J. Immunol. 159: 6077-6082.
22. Leishman, A. J., O. V. Naidenko, A. Attinger, F. Koning, C. J. Lena, Y. Xiong, H. C. Chang, E. Reinherz, M. Kronenberg, and H. Cheroutre. 2001. T cell responses modulated through interaction between CD8alphaα and the nonclassical MHC class I molecule, TL. Science 294: 1936-1939.
23. Kern, P., R. E. Hussey, R. Spoerl, E. L. Reinherz, and H. C. Chang. 1999. Expression, purification, and functional analysis of murine ectodomain fragments of CD8alphaα and CD8alphaβ dimers. J. Biol. Chem. 274: 27237-27243.
24. Garcia, K. C., C. A. Scott, A. Brunmark, F. R. Carbone, P. A. Peterson, I. A. Wilson, and L. Teyton. 1996. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature 384: 577-581.
25. Moody, A. M., Y. Xiong, H. C. Chang, and E. L. Reinherz. 2001. The CD8alphaβ co-receptor on double-positive thymocytes binds with differing affinities to the products of distinct class I MHC loci. Eur. J. Immunol. 31: 2791-2799.
26. Viret, C., and C. A. Janeway, Jr. 1999. MHC and T cell development. Rev. Immunogenet. 1: 91-104.
27. Lee, N. A., D. Y. Loh, and E. Lacy. 1992. CD8 surface levels alter the fate of α/β T cell receptor-expressing thymocytes in transgenic mice. J. Exp. Med. 175: 1013-1025.
28. Robey, E. A., F. Ramsdell, D. Kioussis, W. Sha, D. Loh, R. Axel, and B. J. Fowlkes. 1992. The level of CD8 expression can determine the outcome of thymic selection. Cell 69: 1089-1096.
29. Call, M. E., and K. W. Wucherpfennig. 2005. The T cell receptor: critical role of the membrane environment in receptor assembly and function. Annu. Rev. Immunol. 23: 101-125.
30. Call, M. E., J. Pyrdol, M. Wiedmann, and K. W. Wucherpfennig. 2002. The organizing principle in the formation of the T cell receptor-CD3 complex. Cell 111: 967-979.
31. Dustin, M. L., S. K. Bromley, M. M. Davis, and C. Zhu. 2001. Identification of self through two-dimensional chemistry and synapses. Annu. Rev. Cell Dev. Biol. 17: 133-157.
32. Huang, J., J. Chen, S. E. Chesla, T. Yago, P. Mehta, R. P. McEver, C. Zhu, and M. Long. 2004. Quantifying the effects of molecular orientation and length on two-dimensional receptor-ligand binding kinetics. J. Biol. Chem. 279: 44915-44923.
33. Wu, L., B. Xiao, X. Jia, Y. Zhang, S. Lu, J. Chen, and M. Long. 2007. Impact of carrier stiffness and microtopology on two-dimensional kinetics of P-selectin and P-selectin glycoprotein ligand-1 (PSGL-1) interactions. J. Biol. Chem. 282: 9846-9854.
34. Williams, T. E., S. Nagarajan, P. Selvaraj, and C. Zhu. 2001. Quantifying the impact of membrane microtopology on effective two-dimensional affinity. J. Biol. Chem. 276: 13283-13288.
35. Chesla, S. E., P. Selvaraj, and C. Zhu. 1998. Measuring two-dimensional receptor-ligand binding kinetics by micropipette. Biophys. J. 75: 1553-1572.
36. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
37. Yachi, P. P., J. Ampudia, T. Zal, and N. R. Gascoigne. 2006. Altered peptide ligands induce delayed CD8-T cell receptor interaction-a role for CD8 in distinguishing antigen quality. Immunity 25: 203-211.
38. Kerry, S. E., J. Buslepp, L. A. Cramer, R. Maile, L. L. Hensley, A. I. Nielsen, P. Kavathas, B. J. Vilen, E. J. Collins, and J. A. Frelinger. 2003. Interplay between TCR affinity and necessity of coreceptor ligation: high-affinity peptide-MHC/TCR interaction overcomes lack of CD8 engagement. J. Immunol. 171: 4493-4503.
39. Mamalaki, C., T. Norton, Y. Tanaka, A. R. Townsend, P. Chandler, E. Simpson, and D. Kioussis. 1992. Thymic depletion and peripheral activation of class I major histocompatibility complex-restricted T cells by soluble peptide in T-cell receptor transgenic mice. Proc. Natl. Acad. Sci. USA. 89: 11342-11346.
40. Long, M., J. Chen, N. Jiang, P. Selvaraj, R. P. McEver, and C. Zhu. 2006. Probabilistic modeling of rosette formation. Biophys. J. 91: 352-363.
41. Burshtyn, D. N., and B. H. Barber. 1993. High occupancy binding of antigenic peptides to purified, immunoadsorbed H-2Db β 2m molecules. J. Immunol. 151: 3070-3081.
42. MacLachlan, J., A. T. Wotherspoon, R. O. Ansell, and C. J. Brooks. 2000. Cholesterol oxidase: sources, physical properties and analytical applications. J. Steroid Biochem. Mol. Biol. 72: 169-195.
43. Cahuzac, N., W. Baum, V. Kirkin, F. Conchonaud, L. Wawrezinieck, D. Marguet, O. Janssen, M. Zornig, and A. O. Hueber. 2006. Fas ligand is localized to membrane rafts, where it displays increased cell death-inducing activity. Blood 107: 2384-2391.
44. Xiong, Y., P. Kern, H. Chang, and E. Reinherz. 2001. T Cell Receptor Binding to a pMHCII Ligand Is Kinetically Distinct from and Independent of CD4. J. Biol. Chem. 276: 5659-5667.
45. Gao, G. F., B. E. Willcox, J. R. Wyer, J. M. Boulter, C. A. O'Callaghan, K. Maenaka, D. I. Stuart, E. Y. Jones, P. A. Van Der Merwe, J. I. Bell, and B. K. Jakobsen. 2000. Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8alphaα. J. Biol. Chem. 275: 15232-15238.
46. Wooldridge, L., T. J. Scriba, A. Milicic, B. Laugel, E. Gostick, D. A. Price, R. E. Phillips, and A. K. Sewell. 2006. Anti-coreceptor antibodies profoundly affect staining with peptide-MHC class I and class II tetramers. Eur. J. Immunol. 36: 1847-1855.
47. Denkberg, G., C. J. Cohen, and Y. Reiter. 2001. Critical role for CD8 in binding of MHC tetramers to TCR: CD8 antibodies block specific binding of human tumor-specific MHC-peptide tetramers to TCR. J. Immunol. 167: 270-276.
48. Schott, E., and H. L. Ploegh. 2002. Mouse MHC class I tetramers that are unable to bind to CD8 reveal the need for CD8 engagement in order to activate naive CD8 T cells. Eur. J. Immunol. 32: 3425-3434.
49. Wooldridge, L., S. L. Hutchinson, E. M. Choi, A. Lissina, E. Jones, F. Mirza, P. R. Dunbar, D. A. Price, V. Cerundolo, and A. K. Sewell. 2003. Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surface. J. Immunol. 171: 6650-6660.
50. Fahmy, T. M., J. G. Bieler, and J. P. Schneck. 2002. Probing T cell membrane organization using dimeric MHC-Ig complexes. J. Immunol. Methods. 268: 93-106.
51. Norment, A. M., R. D. Salter, P. Parham, V. H. Engelhard, and D. R. Littman. 1988. Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature 336: 79-81.
52. Dustin, M. L. 1997. Adhesive bond dynamics in contacts between T lymphocytes and glass-supported planar bilayers reconstituted with the immunoglobulin-related adhesion molecule CD58. J. Biol. Chem. 272: 15782-15788.
53. Dustin, M. L., D. E. Golan, D. M. Zhu, J. M. Miller, W. Meier, E. A. Davies, and P. A. van der Merwe. 1997. Low affinity interaction of human or rat T cell adhesion molecule CD2 with its ligand aligns adhering membranes to achieve high physiological affinity. J. Biol. Chem. 272: 30889-30898.
54. Grakoui, A., S. K. Bromley, C. Sumen, M. M. Davis, A. S. Shaw, P. M. Allen, and M. L. Dustin. 1999. The immunological synapse: a molecular machine controlling T cell activation. Science 285: 221-227.
55. Long, M., H. Zhao, K. S. Huang, and C. Zhu. 2001. Kinetic measurements of cell surface E-selectin/carbohydrate ligand interactions. Ann. Biomed. Eng. 29: 935-946.
56. Zhang, F., W. D. Marcus, N. H. Goyal, P. Selvaraj, T. A. Springer, and C. Zhu. 2005. Two-dimensional kinetics regulation of alphaLβ2-ICAM-1 interaction by conformational changes of the alphaL-inserted domain. J. Biol. Chem. 280: 42207-42218.
57. Williams, T. E., P. Selvaraj, and C. Zhu. 2000. Concurrent binding to multiple ligands: kinetic rates of CD16b for membrane-bound IgG1 and IgG2. Biophys. J. 79: 1858-1866.
58. Williams, T. E., S. Nagarajan, P. Selvaraj, and C. Zhu. 2000. Concurrent and independent binding of Fcγ receptors IIa and IIIb to surface-bound IgG. Biophys. J. 79: 1867-1875.
59. Ding, Y. H., B. M. Baker, D. N. Garboczi, W. E. Biddison, and D. C. Wiley. 1999. Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. Immunity 11: 45-56.
60. Devine, L., J. Sun, M. R. Barr, and P. B. Kavathas. 1999. Orientation of the Ig domains of CD8 α β relative to MHC class I. J. Immunol. 162: 846-851.